首页 > 最新文献

Indian Journal of Gastroenterology最新文献

英文 中文
Comment on - Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis. 评论 - 印度抗结核药物诱发肝损伤的发病率和风险因素:系统回顾和荟萃分析。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-23 DOI: 10.1007/s12664-024-01702-2
Amit Pandita, Muhammed Shabil, Sanjit Sah
{"title":"Comment on - Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis.","authors":"Amit Pandita, Muhammed Shabil, Sanjit Sah","doi":"10.1007/s12664-024-01702-2","DOIUrl":"https://doi.org/10.1007/s12664-024-01702-2","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple four symptom-based BEDS score to predict dyssynergic defecation in patients with chronic constipation. 基于四个症状的简单 BEDS 评分可预测慢性便秘患者的排便障碍。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-21 DOI: 10.1007/s12664-024-01697-w
Mayank Jain, Vinodini Agrawal

Background and aims: Dyssynergic defecation (DD) is a disorder of anorectal function characterized by impaired relaxation or inappropriate contraction of pelvic floor muscles on attempted defecation. Based on previous Indian studies, we devised a symptom score (bleeding per rectum, excessive straining for stools, digitation, sense of incomplete evacuation/blockage-BEDS) and tried to determine if it can identify which patients with chronic constipation are more likely to have DD.

Methods: This is a prospective observational cohort study in which consecutive adult patients (> 18 years) with chronic constipation who were referred to our centre for anorectal manometry (ARM) between 2019 and 2023 were included. Prior to tests, patients were asked in detail regarding their symptoms and scoring was done. ARM was done by a single observer. Diagnosis of DD was based on standard criteria. Statistical tests used were median, range and percentages, Chi-square test and Mann-Whitney U-test. The data was analyzed for sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Agreement of symptom-based scoring and DD diagnosis as per criteria was calculated using Cohen's κ coefficient. A p value of < 0.05 was considered statistically significant.

Results: As many as 244 patients (males 140, median age 42 years) formed the study cohort. Of these, 104 (42.6%) have DD. Sense of incomplete evacuation/sense of blockage (72.1% vs. 40%, p < 0.0001), excessive straining (73.1% vs. 22.1%, p < 0.0001) and digitation (28.8% vs. 13.5%, p 0.003) were more commonly reported in patients with DD. Taking a cut-off score of > / = 2, sensitivity of 69.2%, specificity 81.4% and positive likelihood ratio of 3.73 were noted. Similarly, if the score of > / = 3 was considered, the likelihood ratio increased to 4.71 with an increase in specificity (94.29%) and fall in sensitivity (26.92%).

Conclusion: Symptom-based BEDS score of > / = 2 is useful in identifying patients with DD.

背景和目的:排便失调症(DD)是一种肛门直肠功能障碍,其特点是在尝试排便时盆底肌肉放松受损或收缩不当。根据之前的印度研究,我们设计了一种症状评分(直肠出血、排便过度用力、消化不良、排便不尽感/堵塞感-BEDS),并试图确定它是否能识别出哪些慢性便秘患者更有可能患有 DD:这是一项前瞻性观察性队列研究,纳入了2019年至2023年期间转诊至本中心进行肛门直肠测压(ARM)的连续成年慢性便秘患者(大于18岁)。检查前,详细询问患者的症状并进行评分。肛门直肠测压由一名观察者完成。DD的诊断基于标准标准。使用的统计检验包括中位数、范围和百分比、卡方检验和曼-惠特尼U检验。数据分析包括敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。使用 Cohen's κ 系数计算了基于症状的评分与 DD 诊断标准的一致性。结果多达 244 名患者(男性 140 名,中位年龄 42 岁)组成了研究队列。其中 104 人(42.6%)患有 DD。排空不完全感/堵塞感(72.1% 对 40%,P / = 2,灵敏度为 69.2%,特异性为 81.4%,阳性似然比为 3.73)。同样,如果考虑>/=3分,则可能性比值增加到4.71,特异性增加(94.29%),敏感性下降(26.92%):结论:基于症状的 BEDS 评分 > / = 2 分有助于识别 DD 患者。
{"title":"A simple four symptom-based BEDS score to predict dyssynergic defecation in patients with chronic constipation.","authors":"Mayank Jain, Vinodini Agrawal","doi":"10.1007/s12664-024-01697-w","DOIUrl":"https://doi.org/10.1007/s12664-024-01697-w","url":null,"abstract":"<p><strong>Background and aims: </strong>Dyssynergic defecation (DD) is a disorder of anorectal function characterized by impaired relaxation or inappropriate contraction of pelvic floor muscles on attempted defecation. Based on previous Indian studies, we devised a symptom score (bleeding per rectum, excessive straining for stools, digitation, sense of incomplete evacuation/blockage-BEDS) and tried to determine if it can identify which patients with chronic constipation are more likely to have DD.</p><p><strong>Methods: </strong>This is a prospective observational cohort study in which consecutive adult patients (> 18 years) with chronic constipation who were referred to our centre for anorectal manometry (ARM) between 2019 and 2023 were included. Prior to tests, patients were asked in detail regarding their symptoms and scoring was done. ARM was done by a single observer. Diagnosis of DD was based on standard criteria. Statistical tests used were median, range and percentages, Chi-square test and Mann-Whitney U-test. The data was analyzed for sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Agreement of symptom-based scoring and DD diagnosis as per criteria was calculated using Cohen's κ coefficient. A p value of < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>As many as 244 patients (males 140, median age 42 years) formed the study cohort. Of these, 104 (42.6%) have DD. Sense of incomplete evacuation/sense of blockage (72.1% vs. 40%, p < 0.0001), excessive straining (73.1% vs. 22.1%, p < 0.0001) and digitation (28.8% vs. 13.5%, p 0.003) were more commonly reported in patients with DD. Taking a cut-off score of > / = 2, sensitivity of 69.2%, specificity 81.4% and positive likelihood ratio of 3.73 were noted. Similarly, if the score of > / = 3 was considered, the likelihood ratio increased to 4.71 with an increase in specificity (94.29%) and fall in sensitivity (26.92%).</p><p><strong>Conclusion: </strong>Symptom-based BEDS score of > / = 2 is useful in identifying patients with DD.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of practice patterns and adherence to national and international guidelines on the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in India. 印度胃肠病学家和胃肠病学研究员对幽门螺杆菌感染管理的实践模式以及国家和国际指南遵守情况的调查。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-17 DOI: 10.1007/s12664-024-01694-z
Vaneet Jearth, Ashutosh Ishan Yadav, Jimil Shah, Anupam Kumar Singh, Sridhar Sundaram, Vishal Sharma, Usha Dutta, Govind Makharia, Manas Kumar Panigrahi

Background: Patients and primary care providers alike benefit greatly from the expertise of gastroenterologists when it comes to managing Helicobacter pylori (H. pylori) infection. However, information on gastroenterologists' practices in the management of H. pylori infection is scarce in this part of the world. This study aimed at evaluating the practice patterns of gastroenterologists and gastroenterology fellows in India.

Method: This was a cross-sectional questionnaire-based survey of gastroenterologists and gastroenterology fellows working in India.

Results: Total 207 gastroenterologists and 53 fellows filled out the questionnaire. Responses were received from all around India. Approximately 70% of respondents perceive H. pylori to be a gastric pathogen, while 20% regard it as a commensal bacterium. While the proportion of respondents who chose a test and treat method (34.6%) for uninvestigated dyspepsia without alarm symptoms was comparable to empirical proton pump inhibitor (PPI) therapy (38.8%), about one-fifth chose a scope and treat strategy in this setting. Even in the absence of alarm signs, more than half of respondents (61.5%) preferred endoscopic biopsy to detect H. pylori. While rapid urease testing (RUT) was the preferred modality (80%) for detecting H. pylori, about one-third preferred single-site RUT (from the antrum). Only 40% followed the Updated Sydney protocol, while performing biopsies and a majority (78.8%) are unable to discontinue PPIs before testing for H. pylori. PPI-clarithromycin-based triple treatment was the preferred regimen (67%) for first-line eradication, while nearly a quarter of respondents did not utilize bismuth due to concerns about adverse effects.

Conclusion: The survey reveals a lack of adherence to the current H. pylori guidelines for diagnosis, testing and treatment among gastroenterologists and gastroenterology fellows in India. It is vital that scientific societies simplify guidelines, investigate challenges to their effective implementation and execute targeted interventions to increase adherence.

背景:在治疗幽门螺旋杆菌(H. pylori)感染方面,患者和初级保健提供者都能从消化内科医生的专业知识中获益匪浅。然而,世界上有关胃肠病学家治疗幽门螺杆菌感染的信息却很少。本研究旨在评估印度胃肠病学家和胃肠病学研究员的实践模式:方法:这是一项针对在印度工作的胃肠病学家和胃肠病学研究员的横断面问卷调查:共有 207 名消化内科医生和 53 名研究员填写了问卷。收到的答复来自印度各地。约 70% 的受访者认为幽门螺杆菌是一种胃部病原体,20% 的受访者认为它是一种共生细菌。对于未经调查但无报警症状的消化不良,选择检测和治疗方法的受访者比例(34.6%)与经验性质子泵抑制剂(PPI)疗法(38.8%)相当,但约五分之一的受访者在这种情况下选择了范围和治疗策略。即使在没有报警信号的情况下,超过一半的受访者(61.5%)也会选择内镜活检来检测幽门螺杆菌。虽然快速尿素酶检测(RUT)是检测幽门螺杆菌的首选方法(80%),但约三分之一的受访者倾向于单点 RUT(从胃窦)。只有 40% 的人在进行活检时遵循了最新的悉尼方案,大多数人(78.8%)在检测幽门螺杆菌前无法停用 PPI。PPI-卡里霉素三联疗法是一线根除幽门螺杆菌的首选方案(67%),而近四分之一的受访者因担心不良反应而未使用铋剂:调查显示,印度的胃肠病学家和胃肠病学研究员缺乏对现行幽门螺杆菌诊断、检测和治疗指南的遵守。至关重要的是,科学协会应简化指南,调查有效实施指南所面临的挑战,并采取有针对性的干预措施来提高指南的依从性。
{"title":"A survey of practice patterns and adherence to national and international guidelines on the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in India.","authors":"Vaneet Jearth, Ashutosh Ishan Yadav, Jimil Shah, Anupam Kumar Singh, Sridhar Sundaram, Vishal Sharma, Usha Dutta, Govind Makharia, Manas Kumar Panigrahi","doi":"10.1007/s12664-024-01694-z","DOIUrl":"https://doi.org/10.1007/s12664-024-01694-z","url":null,"abstract":"<p><strong>Background: </strong>Patients and primary care providers alike benefit greatly from the expertise of gastroenterologists when it comes to managing Helicobacter pylori (H. pylori) infection. However, information on gastroenterologists' practices in the management of H. pylori infection is scarce in this part of the world. This study aimed at evaluating the practice patterns of gastroenterologists and gastroenterology fellows in India.</p><p><strong>Method: </strong>This was a cross-sectional questionnaire-based survey of gastroenterologists and gastroenterology fellows working in India.</p><p><strong>Results: </strong>Total 207 gastroenterologists and 53 fellows filled out the questionnaire. Responses were received from all around India. Approximately 70% of respondents perceive H. pylori to be a gastric pathogen, while 20% regard it as a commensal bacterium. While the proportion of respondents who chose a test and treat method (34.6%) for uninvestigated dyspepsia without alarm symptoms was comparable to empirical proton pump inhibitor (PPI) therapy (38.8%), about one-fifth chose a scope and treat strategy in this setting. Even in the absence of alarm signs, more than half of respondents (61.5%) preferred endoscopic biopsy to detect H. pylori. While rapid urease testing (RUT) was the preferred modality (80%) for detecting H. pylori, about one-third preferred single-site RUT (from the antrum). Only 40% followed the Updated Sydney protocol, while performing biopsies and a majority (78.8%) are unable to discontinue PPIs before testing for H. pylori. PPI-clarithromycin-based triple treatment was the preferred regimen (67%) for first-line eradication, while nearly a quarter of respondents did not utilize bismuth due to concerns about adverse effects.</p><p><strong>Conclusion: </strong>The survey reveals a lack of adherence to the current H. pylori guidelines for diagnosis, testing and treatment among gastroenterologists and gastroenterology fellows in India. It is vital that scientific societies simplify guidelines, investigate challenges to their effective implementation and execute targeted interventions to increase adherence.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic enteropathy associated with SLCO2A1 gene (CEAS) in Indian adolescents: Apropos of two cases. 印度青少年与 SLCO2A1 基因相关的慢性肠病(CEAS):两个病例的启示
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-17 DOI: 10.1007/s12664-024-01698-9
Aditi Kumar, Janvi Sirwani, Tara Prasad Tripathy, Susama Patra, Manas Kumar Panigrahi, Debasish Sahoo, Sonali Mohapatra, Amit Kumar Satapathy
{"title":"Chronic enteropathy associated with SLCO2A1 gene (CEAS) in Indian adolescents: Apropos of two cases.","authors":"Aditi Kumar, Janvi Sirwani, Tara Prasad Tripathy, Susama Patra, Manas Kumar Panigrahi, Debasish Sahoo, Sonali Mohapatra, Amit Kumar Satapathy","doi":"10.1007/s12664-024-01698-9","DOIUrl":"https://doi.org/10.1007/s12664-024-01698-9","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic ultrasound elastography-guided fine needle aspiration for solid pancreatic lesions: Down but not out! 内镜超声弹性成像引导下的胰腺实变细针穿刺术:下而不出!
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-15 DOI: 10.1007/s12664-024-01696-x
Praveer Rai
{"title":"Endoscopic ultrasound elastography-guided fine needle aspiration for solid pancreatic lesions: Down but not out!","authors":"Praveer Rai","doi":"10.1007/s12664-024-01696-x","DOIUrl":"https://doi.org/10.1007/s12664-024-01696-x","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The etiological profile of chronic organic non-bloody diarrhea in India: A closer look. 印度慢性器质性非血性腹泻的病因概况:近距离观察。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-15 DOI: 10.1007/s12664-024-01693-0
Uday C Ghoshal, Subhamoy Das, Mahesh K Goenka
{"title":"The etiological profile of chronic organic non-bloody diarrhea in India: A closer look.","authors":"Uday C Ghoshal, Subhamoy Das, Mahesh K Goenka","doi":"10.1007/s12664-024-01693-0","DOIUrl":"https://doi.org/10.1007/s12664-024-01693-0","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the minimal inhibitory concentration of glycine against indigenous strain of Helicobacter pylori isolated from gastric biopsies. 确定甘氨酸对从胃活检组织中分离出的幽门螺旋杆菌本地菌株的最小抑制浓度。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-05 DOI: 10.1007/s12664-024-01695-y
Parisa Javanbakhat, Zahra Hosseinali, Rasool Nemati, Abbas Yazdanbod, Roghayeh Teimourpour
{"title":"Determining the minimal inhibitory concentration of glycine against indigenous strain of Helicobacter pylori isolated from gastric biopsies.","authors":"Parisa Javanbakhat, Zahra Hosseinali, Rasool Nemati, Abbas Yazdanbod, Roghayeh Teimourpour","doi":"10.1007/s12664-024-01695-y","DOIUrl":"https://doi.org/10.1007/s12664-024-01695-y","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A typical case of IgG4 related sclerosing cholangitis. 一个典型的 IgG4 相关硬化性胆管炎病例。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 DOI: 10.1007/s12664-024-01687-y
Varsha Vishwakarma, Kaushal Madan, Pallavi Garg, Richa Bhargava
{"title":"A typical case of IgG4 related sclerosing cholangitis.","authors":"Varsha Vishwakarma, Kaushal Madan, Pallavi Garg, Richa Bhargava","doi":"10.1007/s12664-024-01687-y","DOIUrl":"https://doi.org/10.1007/s12664-024-01687-y","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simethicone and N-acetyl cysteine in improving mucosal visibility: Towards a "clearer view" during endoscopy. 西甲硅氧烷和n -乙酰半胱氨酸在改善粘膜可见性中的作用:在内窥镜检查中获得“更清晰的视野”。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 DOI: 10.1007/s12664-023-01482-1
Akash Roy, Mahesh K Goenka
{"title":"Simethicone and N-acetyl cysteine in improving mucosal visibility: Towards a \"clearer view\" during endoscopy.","authors":"Akash Roy, Mahesh K Goenka","doi":"10.1007/s12664-023-01482-1","DOIUrl":"10.1007/s12664-023-01482-1","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":"863-865"},"PeriodicalIF":2.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138451383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of endoscopic retrograde cholangiopancreatography in pediatric pancreatic and biliary disorders. 内镜逆行胰胆管造影术治疗小儿胰腺和胆道疾病的安全性和有效性。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-02-17 DOI: 10.1007/s12664-023-01498-7
Love Garg, Arun Vaidya, Aditya Kale, Amrit Gopan, Abu Ansari, Biswa Ranjan Patra, Akash Shukla

Introduction: There is sparse data from India on indications, technical success, safety and outcomes of endoscopic retrograde cholangiopancreatography (ERCP) using standard adult duodenoscope in the pediatric population.

Methods: Retrospective analysis of prospectively maintained electronic endoscopy and clinical database was performed to identify pediatric patients (age ≤ 18 years) who underwent ERCP between January 2017 and December 2022. Demographics and procedural details including indications, cholangio-pancreatogram findings, endotherapy type performed, technical and clinical success and complications were noted.

Results: As many as 150 pediatric patients were included of whom 88 had pancreatic (mean age-13.7 years) and 62 had biliary disease (mean age- 14.9 years). Common pancreatic ERCP indications were chronic pancreatitis (n = 45 [51.1%]), pancreatic duct disruption fistula (n = 21 [23.9%]) and recurrent acute pancreatitis (n = 16 [18.2%]). Among biliary indications were choledocholithiasis (n = 29 [46.8%]), benign bile duct strictures (n = 13 [21%]), bile duct injury/leak and biliary stent removal (n = 7 [11.3%]) , choledochal cyst (n = 5  [8.1%]) and pancreatic mass causing biliary compression (n = 1 [1.6%]). Technical success in pancreatic and biliary ERCP was 94.3% and 95.2%, respectively, and clinical success was 84.1% and 93.5%, respectively. Most common complications following pancreatic ERCPs were acute pancreatitis (n = 9 [10.2%]) (mild = 5, moderate = 4) patients and post sphincterotomy bleed in one (1.1%). Among biliary ERCPs, post ERCP pancreatitis was seen in (n = 3 [4.8%]) (mild = 2, moderate = 1).

Conclusion: ERCP can be safely and effectively performed in children using standard duodenoscope. Chronic pancreatitis, choledocholithiasis and pancreatic divisum are common pediatric ERCP indications.

导言:印度有关儿科使用标准成人十二指肠镜进行内镜逆行胰胆管造影术(ERCP)的适应症、技术成功率、安全性和结果的数据非常稀少:对前瞻性维护的电子内镜和临床数据库进行了回顾性分析,以确定在 2017 年 1 月至 2022 年 12 月期间接受 ERCP 的儿科患者(年龄小于 18 岁)。研究人员记录了人口统计学和手术细节,包括适应症、胆胰造影结果、内镜治疗类型、技术和临床成功率以及并发症:结果:共纳入150名儿童患者,其中88人患有胰腺疾病(平均年龄13.7岁),62人患有胆道疾病(平均年龄14.9岁)。常见的胰腺ERCP适应症为慢性胰腺炎(45例[51.1%])、胰管瘘(21例[23.9%])和复发性急性胰腺炎(16例[18.2%])。胆道适应症包括胆总管结石(29 人[46.8%])、良性胆管狭窄(13 人[21%])、胆管损伤/漏和胆道支架切除(7 人[11.3%])、胆总管囊肿(5 人[8.1%])和胰腺肿块导致胆道受压(1 人[1.6%])。胰腺和胆道ERCP的技术成功率分别为94.3%和95.2%,临床成功率分别为84.1%和93.5%。胰腺ERCP术后最常见的并发症是急性胰腺炎(9例[10.2%])(轻度5例,中度4例)和括约肌切开术后出血(1例,1.1%)。在胆道ERCP中,ERCP术后胰腺炎的患者有3例[4.8%](轻度2例,中度1例):结论:使用标准十二指肠镜可安全有效地为儿童进行ERCP。慢性胰腺炎、胆总管结石和胰腺憩室是常见的儿童ERCP适应症。
{"title":"Safety and efficacy of endoscopic retrograde cholangiopancreatography in pediatric pancreatic and biliary disorders.","authors":"Love Garg, Arun Vaidya, Aditya Kale, Amrit Gopan, Abu Ansari, Biswa Ranjan Patra, Akash Shukla","doi":"10.1007/s12664-023-01498-7","DOIUrl":"10.1007/s12664-023-01498-7","url":null,"abstract":"<p><strong>Introduction: </strong>There is sparse data from India on indications, technical success, safety and outcomes of endoscopic retrograde cholangiopancreatography (ERCP) using standard adult duodenoscope in the pediatric population.</p><p><strong>Methods: </strong>Retrospective analysis of prospectively maintained electronic endoscopy and clinical database was performed to identify pediatric patients (age ≤ 18 years) who underwent ERCP between January 2017 and December 2022. Demographics and procedural details including indications, cholangio-pancreatogram findings, endotherapy type performed, technical and clinical success and complications were noted.</p><p><strong>Results: </strong>As many as 150 pediatric patients were included of whom 88 had pancreatic (mean age-13.7 years) and 62 had biliary disease (mean age- 14.9 years). Common pancreatic ERCP indications were chronic pancreatitis (n = 45 [51.1%]), pancreatic duct disruption fistula (n = 21 [23.9%]) and recurrent acute pancreatitis (n = 16 [18.2%]). Among biliary indications were choledocholithiasis (n = 29 [46.8%]), benign bile duct strictures (n = 13 [21%]), bile duct injury/leak and biliary stent removal (n = 7 [11.3%]) , choledochal cyst (n = 5  [8.1%]) and pancreatic mass causing biliary compression (n = 1 [1.6%]). Technical success in pancreatic and biliary ERCP was 94.3% and 95.2%, respectively, and clinical success was 84.1% and 93.5%, respectively. Most common complications following pancreatic ERCPs were acute pancreatitis (n = 9 [10.2%]) (mild = 5, moderate = 4) patients and post sphincterotomy bleed in one (1.1%). Among biliary ERCPs, post ERCP pancreatitis was seen in (n = 3 [4.8%]) (mild = 2, moderate = 1).</p><p><strong>Conclusion: </strong>ERCP can be safely and effectively performed in children using standard duodenoscope. Chronic pancreatitis, choledocholithiasis and pancreatic divisum are common pediatric ERCP indications.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":" ","pages":"1037-1044"},"PeriodicalIF":2.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139897969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1